A randomised, double-blind, placebo-controlled, parallel group, repeat dose study to assess the effect of SB-480848 [darapladib] on overall asthma control in adult subjects with persistent asthma controlled on stable, low-dose, inhaled corticosteroids.
Phase of Trial: Phase I
Latest Information Update: 07 Dec 2016
At a glance
- Drugs Darapladib (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jan 2007 New trial centres added